Background: This study investigated whether the combination of sodium valproate (SV) with L-cysteine (LC) can decrease the SV toxicity of kidneys. SV caused alternation in oxidative/antioxidant balance. Methods: Biochemical estimations included the determination of oxidative stress markers like thiobarbituric acid-reactive substances in kidney tissue, and enzymatic antioxidant activities such as superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione reductase as well as total antioxidant capacity were evaluated in renal tissues. Creatinine and uric acid levels in the serum were also determined to assess kidney function. Pathological examination of the kidney was also performed. Results: Increasing the levels of lipid peroxidation and decreasing the enzymatic activity (SOD, CAT, and GPx) as well as total antioxidant capacity of rats was shown with different doses of SV. Impairment in renal function tests suggests a decreased glomerular filtration rate, as serum creatinine was elevated. Histopathological changes of kidney tissue treated with SV reveal the proximal and the distal convoluted tubules that show hydropic changes (small white vacuoles within the cytoplasm and the glomeruli show hypercellularity).
Introduction
The increased clinical use of valproate has been accompanied by reports of hepatic dysfunction and renal tubular defects [1] [2] [3] . Valproic acid has been used worldwide as a broad-spectrum antiepileptic drug with specific indications for many forms of epilepsy and many types of seizures affecting both children and adults [4] . Nevertheless, along with the desired effects, sodium valproate (SV) therapy can induce side effects such as dyspepsia, obesity, hematological toxicity, teratogenicity, idiosyncratic hepatotoxicity and important endocrine dysfunctions [3, 5, 6] .
SV is assumed to have multiple mechanisms of action on the basis those extensive laboratory investigations that may confer certain advantages when treating patients with multiple seizure types or in whom the diagnosis is initially unclear. This may reduce the likelihood of tolerance and increase the possibility of synergism between mechanisms but has also been suggested to elevate the propensity for adverse effects [7] . Valproic acid (VPA) is a substrate for the fatty acid β-oxidation (FAO) pathway, which takes place primarily in mitochondria. The toxicity of valproate has long been considered to be due primarily to its interference with mitochondrial β-oxidation [4] . The metabolism of the drug, and its effects on enzymes of FAO and their cofactors such as CoA and/or carnitine were reviewed.
The efficacy of SV in generalized absence epilepsy is believed to be mediated by blockade of the low-voltageactivated (LVA) T-type calcium channel in the soma and dendrites of the thalamic relay and reticular neurons [7] .
Several studies demonstrated that chronic treatment with SV caused alteration in the liver [3, 8] , change in the brain [9, 10] and reversible changes in testes [11, 12] of rats. However, the exact mechanism is not thoroughly investigated, and also there are no data available on the ameliorative effect of L-cysteine (LC) on the SV in rats.
LC is called a semi-essential amino acid because humans can synthesize it from the amino acid methionine [13, 14] . Along with a host of proteins, LC is a precursor of glutathione (GSH), which is considered pivotal for the detoxification of cellular oxidative stress [13] . LC and its derivatives are large groups of exogenous antioxidant drugs that protect against oxidative tissue injury. This effect may be directly related to the drug itself (e.g. inactivation of hydroxyl radicals) [15] . The maintenance of free sulfhydryl groups is considered crucial to the biological functions of many proteins [16] .
Oxidative stress and the role of reactive oxygen species in disease and toxicity have been major issues in biomedical sciences [3, 17, 18] . Free radicals are continuously produced in vivo, and there are a number of protective antioxidant enzymes [superoxide dismutase (SOD), catalase (CAT), glutathione S-transferase, glutathione peroxidase (GPx), and glutathione reductase] for dealing with these toxic substances. The delicate balance between the production and catabolism of oxidants is critical for maintenance of biological functions [19] .
Therefore, in this study, we evaluated the level of protection of LC against the renal toxicity of SV in rats. We also determined the effect of different doses of the SV and LC in toxicity. Serum renal markers of damages were measured in rats, including uric acid and creatinine. Enzymatic antioxidant activities such as SOD, CAT, GPx, glutathione reductase as well as levels of malondialdehyde (MDA) and total antioxidant capacity were evaluated in kidney homogenate tissue. Pathological examination of the kidney was also performed.
Materials and methods

Chemicals
SV was purchased from Sigma Chemical Co. (St. Louis, MO, USA). The tested dose of SV (100 and 500 mg/kg BW) was chosen based on the previous studies of Khan et al. [20] . LC was purchased from Sigma Chemical Co. It was given in a dose of 100 mg/kg [21] . All other chemicals used in the experiment were analytical grade.
Experimental animals
The animals were obtained from the animal house of Faculty Veterinary Medicine, Zagazig University. Sixty adult male albino rats weighing 200 g were housed in metal cages and bedded with wood shavings and kept under standard laboratory conditions of aeration and room temperature at about 25 °C with 12/12 light and dark cycle. The animals were allowed free access to standard diet (Valley Group Co., Sigma-Aldrich, Egypt) and water ad libitum throughout the experimental period. We have followed the European community Directive (86/609/EEC) and national rules on animal cares that were carried out in accordance with the NIH Guidelines for the Care and Use of Laboratory Animals 8th edition. The animals were accommodated to the laboratory conditions for 2 weeks before being experimented, one group served as control and five treated groups.
Experimental design
The animals were divided into six groups (n = 10): the first control group was treated with saline as vehicle; the second and third groups were treated with low and high doses of SV (SV-LD and SV-HD; 100 and 500 mg kg −1 , respectively) according to Khan et al. [20] . The fourth group was treated with LC (100 mg kg −1 ) as per Ahmed et al. [21] , and fifth and sixth groups were treated with SV-LD+LC and SV-HD+LC, respectively. All the groups were treated orally by a gastric tube for 30 successive days.
Collection of blood
Blood samples of the fasted rats were collected from the medical retro-orbital venous plexus immediately with capillary tubes (Micro Hematocrit Capillaries, Mucaps) under ether anesthesia [22] . Then, the blood was centrifuged at 3000 rpm for 15 min and serum was collected for different biochemical analyses.
Kidney biomarker
The levels of serum uric acid and creatinine were estimated spectrophotometric using commercial diagnostic kits (Jiancheng Institute of Biotechnology, Nanjing, China).
Preparation of tissue homogenates for measurement of antioxidant enzymes
The remainder tissues of the kidney (about 0.25 g) were used for the analysis of oxidative stress and antioxidant parameters. They were washed with physiological saline (0.9%) for the removal of blood, and later the fatty parts were removed so as not to record a reading on the spectrophotometer for blood antioxidant enzymes, and so as to get a more accurate reading for antioxidant enzymes in tissue homogenates only; then we blotted the tissues over a piece of filter paper. Prior to dissection, the tissues were perfused with a 50 mM sodium phosphate buffer saline (100 mM Na 2 HPO 4 /NaH 2 PO 4 ) (pH 7.4) and 0.1 M ethylenediamine tetraacetic acid (EDTA) to remove any red blood cells and clots. Then, the tissues were homogenized in 5 mL cold buffer per gram tissue and centrifuged at 5000 rpm for 1/2 h. The resulting supernatant was transferred into Eppendorf tubes and preserved in a deep freeze until used for various antioxidant assays.
Determination of oxidative and antioxidant parameters
The extent of lipid peroxidation (LPO) was estimated as the concentration of thiobarbituric acid reactive product MDA by using the method of Ohkawa et al. [23] . MDA concentrations were determined using 1,1,3,3-tetraethoxypropane as standard and expressed as μmol/g tissue. SOD activity was measured by assaying the auto-oxidation of pyrogallol at 440 nm for 3 min [24] . One unit of SOD activity was calculated as the amount of protein that caused 50% pyrogallol auto-oxidation inhibition. A blank without homogenate was used as a control for non-enzymatic oxidation of pyrogallol in Tris-EDTA buffer (50 mM Tris, 10 mM EDTA, pH 8.2). The SOD activity is expressed as U/mg protein.
CAT activity was measured by assaying the hydrolysis of H 2 O 2 and the resulting decrease in absorbance at 240 nm over a 3-min period at 25 °C [25] . Before determination of the CAT activity, samples were diluted 1:9 with 1% (v/v) Triton X-100. CAT activity is expressed as mmol/mg protein.
GPx activity was determined as a method of Hafeman et al. [26] . The peroxide substrate (ROOH), glutathione reductase (GRx) and nicotinamide adenine dinucleotide phosphate (NADPH) are included in the reaction mixture. The formation of the oxidized form of glutathione (GSSG) that is catalyzed by GPx is coupled to the recycling of GSSG back to the reduced form of glutathione (GSH) using GRx. NADPH is oxidized to NADP + . The change in A 340 due to NADPH oxidation is monitored and is indicative of GPx activity. The activity of GPx was expressed in terms of mmol GSH consumed/min/g wet weight tissue.
GRx activity was determined using a method previously described by Couri and Abdel-Rahman [27] . The enzymatic reaction proceeded at a rate directly proportional to GSH concentration. The unit of GRx activity was defined as an increase in the log(GSH) of 0.001 min −1 . Total antioxidant capacity (TAC) was determined using a ferric reducing antioxidant power assay according to the method of Prieto et al. [28] . Ferric reducing antioxidant power (FRAP) reagent [300 mM acetate buffer, pH 3.6, 10 mM 2,4,6-tri(Z-pyridyl)-S (triazine, 99%)] in 40 mM HCl and 20 mM FeCl 3 ·6H 2 O in the ratio of 10:1:1 was prepared. FRAP reagent (1.5 mL) was added to 50 μL of homogenate liver, brain, testis and kidney tissues, and incubated at 37 °C for exactly 5 min. The change in absorbance was measured at 593 nm due to the formation of a blue colored Fe II -tripyridyl triazine complex from the colorless oxidized Fe III form the action of electron-donating antioxidants. The absorbance of the sample was read against a reagent blank (1.5 mL FRAP reagent and 50 μL distilled water) at 593 nm.
Histological evaluation
For histological examination, a portion of the liver was fixed in 10% neutral buffered formalin embedded in paraffin, sectioned and stained with hematoxylin and eosin as described by Gabe [29] . Then semi-thin sections (0.5-1 μm) were prepared by using LKB ultramicrotome. The sections were stained with toluidine blue, examined with a light microscope and photographed.
The histopathological scoring analysis was performed according to Lobenhofer et al. [30] , and the assessment was expressed as the sum of the individual score grades as follows: − − − − for the absence of the changes in the animals, + + + + presented the changes that were found in 90% of the group, + + + − for the changes that occurred in almost 80% of the group, + + − − for the changes that were observed in 50% of the animals, and finally, − − − + for rare alternation within 25% of the rats.
Results
Biomarkers of renal damage
Levels of uric acid and creatinine are two markers of renal function, which are used to diagnose acute and chronic renal diseases. Compared with the control group, uric acid was significantly decreased in rats receiving 100 mg/kg of LC alone (Figure 1 ). LC lowered the creatinine level, but there is no significant difference between control rats. SV increases the level of serotonin in a dose-dependent manner. More over, in rats treated with a combination of SV-LD and LC, uric acid was detected in the normal range of concentrations (Figure 1) . LC failed to induce a significant change in uric acid and creatinine levels when combined with SV-HD.
Oxidative stress and antioxidant biomarkers
MDA, which is a marker of oxidative damage, was detected. LPO levels in the kidney were greatly increased in all SV groups as compared with the control (Figure 2) . In rats treated with LC and SV-LD or SV-HD, the amount of MDA decreased toward normal in a dose-dependent manner as compared with its related groups. There was a significant difference between SV-LD+LC and SV-HD+LC.
CAT, SOD and GRx activities were significantly decreased in rats treated with SV as compared with the control (Figure 3) . Treatment of SV rats with LC restored the activities of mentioned antioxidant enzymes toward almost the normal values, statistically different from those of groups treated with SV alone. GPx activity increased significantly in the animals treated in combination with SV-DH and LC as compared with SV-HD alone. Figure 4 presents the levels of TAC of control for the LC, SV-LD and SV-HD groups, which were 95.8%, 95.0%, 75.0% and 54.0%, respectively. LC restored the TAC level in the rats treated with high dose of SV. 
Histopathology
The histopathological findings of the kidney were as follows. Control and LC groups ( Figure 5A and B, respectively) showed normal kidney tissue, and no evidence of abnormality was detected. Rats treated with SV-LD showed very slight inflammatory cell infiltration and focal interstitial hemorrhage ( Figure 5C ). Animals treated with SV-HD showed hypercellular glomeruli with mesangial cell proliferation ( Figure 5D ). Renal glomeruli and tubules with few scattered congested blood vessels were observed in rats treated with SV-LD and LC ( Figure 5E ). SV-HD and LC caused cloudy swelling in renal tubules ( Figure 5F ).
The histopathological changes in the kidney are graded and summarized in Table 1 . Histological grading was done according to five grades as follows: absence of the change in the animals of the studied group (0), a marker which was often found in all the studied animals of a group (1), a moderate change which was observed in almost all the studied animals of a group (4), a change not so often observed in all animals of a group (2 and 5) and a change which was rare within a group (3). 
Discussion
We investigated whether the renal toxicity caused by sub-chronic administration of SV could be prevented or ameliorated by treatment with LC. The oxidative and antioxidant mechanisms of SV toxicity to kidney have not been discussed before. Tabatabaei and Abbott [31] reported that the cytotoxic activity of SV is the result of the generation of hydrogen peroxide and the production of highly reactive hydroxyl radicals. This could be the reason behind increasing the level of LPO and decreasing the enzymatic activity (SOD, CAT, and GPx) and total antioxidant capacity of rats in this study. To our knowledge, this is the first report describing the effect of LC on the implication of free radicals in the toxicity of SV on rats.
Altered glomerular filtration rate by SV, manifested by an increase in serum creatinine levels, could be related to free radical injury since the redox status was affected in our investigation. Impairment in renal function tests suggests a decreased glomerular filtration rate, as serum creatinine was elevated. To clarify the underlying mechanism(s) of SV toxicity, this study revealed that SV administration for 4 weeks altered kidney function represented by elevated uric acid and creatinine levels, hence suggesting decreased blood flow.
Uric acid, while being currently considered an antioxidant in the extracellular environment, has direct prooxidative effects once it gains entry into cells [32] ; thereby the rise of the uric acid in the plasma was reported to be unaltered the level of LPO in kidneys of mice envenomed by Crotalus durissus terrificus [33] .
Another explanation may be afforded by the effect of SV; it showed effects on redox potential in the kidney where it raised its LPO content and decreased the activation of antioxidant enzymes as well as the TAC level. This effect is similar to those reported by Hovinga et al. [34] , who found unaltered serum creatinine and bilirubin levels by valproate; its nephrotoxic effect was evidenced by elevated kidney lipid peroxide content. These data could be explained by the fact that the valproate-induced minor signs of tubular dysfunction did not affect renal function tests as reported by Hergüner et al. [35] .
The involvement of LPO in SV-induced renal tubular disorder is based on several lines of evidence. Valproate treatment decreased the rate of oxidized glutathione released into the bile [36] . Although LPO may play a role in SV toxicity, a detailed time course of biochemical changes in the kidney following sub-chronic exposure has not been reported and may be critical to understanding the mechanism of SV toxicity. These experiments were designed to demonstrate the initiation of antioxidant and the role of LPO in SV toxicity. SV may undergo omega oxidation and delta-dehydrogenation [37] producing unsaturated derivatives (2-n-propyl-4-pentanoic acid; 2-n-propyl-2 (E) pentanoic acid; 2 hydroxy, 3 hydroxy, and 4 hydroxy valproic acid) by the inhibition of either mitochondrial or microsomal P-450 [38] . This may generate reactive oxygen species, to combine with polyunsaturated lipids and generate lipid hydroperoxides. SV, its omega oxidation products and delta dehydrogenation moieties are reported to be depressants of gluconeogenesis [39] , and may inhibit the mitochondrial or microsomal reactions, a rate limiting factor.
Valproic acid treatment caused significant nuclear alterations in normal drug-filtering organs (liver and kidney tissue), due to the fact that valproic acid acts as a histone deacetylase inhibitor and promising anticancer agent that changes the acetylation status of histones and loosens the chromatin structure.
On the other hand, histopathological changes of kidney tissue treated with SV reveal the proximal and the distal convoluted tubules that show hydropic changes (small white vacuoles within the cytoplasm) and the glomeruli that show hypercellularity. However, the group treated with LC showed normal histology; no histopathological changes could be detected in the glomerulus, proximal and distal convoluted tubules. This result was in agreement with Amel et al. [40] , who studied the effect of some antioxidant on sodium valproate-induced embryotoxicity in pregnant mice.
Hergüner et al. [35] suggest that SV does not have a significant dose-or time-related side effect on renal functions. Minor biochemical dysfunctions related to long-term SV therapy are reversible, and the minimal renal fibrosis that showed histopathologically is not clinically important. The renal tissues of rats are known to show similar metabolic and histological patterns with human renal tissues. No renal dysfunction was expected in humans because there were no clinically statistically significant renal side effects in their study. The treatment with SV in high dose in this study induced highly oxidative stress compared with the treatment with SV in low dose. Therefore, it is considered safe because it did not induce such damage caused by the high dose of SV.
Treatment with LC significantly decreased the LPO levels in renal tissues, suggesting that they offer protection by preserving the structural integrity of the renal membrane against SV-induced oxidative stress. The protective efficacy of LC may be due to provoking the activity of free radical scavenging enzyme systems and render protection against SV-induced kidney damage and oxidative stress.
LC belongs to the class of organic compounds known as l-alpha-amino acids which have the L-configuration of the alpha-carbon atom. Because of the ability of thiols to undergo redox reactions and because it is an important source of sulfur in human metabolism, LC has antioxidant properties [41] . Moreover, the sulfide in iron-sulfur clusters and in nitrogenase is extracted from cysteine, which is converted to alanine in the process. So cysteine could offer the benefit of increasing the beneficial antioxidant glutathione, which is diminished in oxidative stress status [41] . Therefore, our study aimed to highlight the important role of LC in reducing oxidative stress in kidney and especially in the case of treatment with SV.
Cysteine had been showed a protective effect against other drugs and chemicals. Katayama et al. [42] demonstrated the possible protective role of cysteine against cisplatin nephrotoxicity. Using the acetaminophen-cysteine decreased the acetaminophen nephrotoxicity [43] .
The VPA-induced injury was associated with a dosedependent rise in serum liver enzymes and kidney markers as well as a decline in plasma albumin. The VPA-mediated hepatotoxicity is a fatal, irreversible idiosyncratic reaction that is characterized by microvesicular steatosis and necrosis [44] . Although the mechanisms involved are not fully characterized, a large body of evidence suggests that reactive VPA metabolites (i.e. 4-ene-VPA and its subsequent metabolite, 2,4-diene-VPA) may mediate the hepatotoxicity by inhibiting mitochondrial β-oxidation of FAs. Further, excessive generation of reactive oxygen species (ROS) (such as peroxides and hydroxyl radical) may associate with the toxicity of VPA, possibly as a consequence of disrupting the liver antioxidant machinery [45] .
We can conclude that SV induces oxidative stress and histopathological changes in renal tissues and the LC has the antioxidant capacity which decreases the renal marker dysfunctions. LC has significant protection against SV-induced toxicity by its ability to ameliorate the LPO through the free radical scavenging activity, which enhanced the levels of the antioxidant defense system. It indicates that LC as antioxidant is very important in the treatment of epilepsy with SV.
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